QUALITY CONTROL TESTING OF CONVENTIONAL CLOPIDOGREL BISULFATE TABLETS MARKETED IN IRAQ

MAZIN THAMIR ABDUL-HASAN; ABULFADHEL JABER NEAMAH Al-SHAIBANI; ALI N. WANNAS; KARRAR MOHAMMED HASAN AL-GBURI

doi:10.22159/ijap.2022v14i1.43331

Authors

MAZIN THAMIR ABDUL-HASAN Department of Pharmaceutics, Faculty of Pharmacy, University of Kufa, Al-Najaf, Iraq https://orcid.org/0000-0001-7682-838X
ABULFADHEL JABER NEAMAH Al-SHAIBANI Department of Pharmaceutics, Faculty of Pharmacy, University of Kufa, Al-Najaf, Iraq https://orcid.org/0000-0002-4838-7027
ALI N. WANNAS Department of Pharmaceutics, Faculty of Pharmacy, University of Kufa, Al-Najaf, Iraq https://orcid.org/0000-0002-1563-7026
KARRAR MOHAMMED HASAN AL-GBURI Department of Clinical Pharmacy, Faculty of Pharmacy, University of Kufa, Al-Najaf, Iraq https://orcid.org/0000-0003-1162-5789

DOI:

https://doi.org/10.22159/ijap.2022v14i1.43331

Keywords:

Oral tablets, Clopidogrel bisulfate, Biopharmaceutics , classification system (BCS) solubility

Abstract

Objective: This study was employed to evaluate the quality of marketed oral tablets containing clopidogrel bisulfate. Tablets produced by various companies and commercialized in the Iraq market were used in the study.

Methods: Batches of clopidogrel bisulfate conventional tablets (containing 75 mg of drug) were exposed to the quality control tests. These tests involved friability, weight variation, hardness, drug content, disintegration time, and in vitro release study; these tests were conducted depending on USP pharmacopeia.

Results: The data indicate that all batches of clopidogrel bisulfate complied with the limitations of USP pharmacopeia for variation of weight, results of the hardness of tablets were 7.2-9.6 Kg/cm². Friability value (% loss) was less than one, which was within the required limits. The time of disintegration was less than 25 min in both artificial gastric fluid (AGF) and artificial intestinal fluid (AIF). Drug content was observed between 97.1 % and 99.8 %, indicating compliance with the limits of pharmacopeia (85-115 %). An in vitro release study of batches was greater than 80 % within 25 min.

Conclusion: All batches of clopidogrel bisulfate were manufactured within the criteria of tablet manufacturing. The quality control tests of tablets showed acceptable pharmaceutical properties (effectiveness and safety) that lie within the limits of USP pharmacopeia.

Downloads

Download data is not yet available.

References

Xhafaj D, Malaj L, Mileti M. A comparative quality control study of cetirizine hydrochloride 10 mg tablets on the Albanian pharmaceutical market. Int J Pharm Pharm Sci. 2015;7(1):504-7.

Shabana Md. A review on the quality control analysis of oral dosage form: tablets. Res Rev J Pharm Pharm Sci. 2016;5(2):108-14.

Uddin M, Mamun A, Rashid M, Asaduzzaman M. In-process and finished products quality control tests for pharmaceutical capsules according to pharmacopoeias. Br J Pharm Res. 2016;9(2):1-9. doi: 10.9734/BJPR/2016/22044.

Asif H, Syed Masudur RD, Sayed Koushik A, Masud Kaisar M. Quality control studies on cetirizine hydrochloride tablets available in Bangladeshi drug market. Int J Pharm Biol Sci. 2013;3(1):349-54.

Al-nuss R, El-zein H. Enhancement of candesartan cilexetil dissolution rate by using different methods. Asian J Pharm Clin Res. 2015;8(1):320-6.

Akter AM, Begh ZA, Parvez A, Islam F. Quality analysis of different marketed brands of carbamazepine available in Bangladesh. Pharmacologyonline. 2019;2:105-12.

Bandyopadhyay S. An explicit review on quantitative estimation of candesartan cilexetil employing various analytical techniques. Pharm Anal Acta. 2013;4(6). doi: 10.4172/2153-2435.1000254.

Ghareeb MM, Neamah AJ. Formulation and characterization of nimodipine nanoemulsion as ampoule for oral route. Int J Pharm Sci Res. 2017;8(2):591-602.

Gupta MM, Gupta M. Comparative pharmaceutical quality control testing of different brands of paracetamol tablets available in the Trinidad and Tobago, West Indies. Int J Pharm Sci Res. 2016;7(7):2830-6.

Ramakrishna S, Mihira V, Vyshnavi K, Ranjith V. Design and evaluation of drug release kinetics of meloxicam sustained release matrix tablets. Int J Curr Pharm Res. 2012;4(1):90-9.

Shah MR, Nasiri MI, Anwer S, Ali T, Zaheer K, Ahmed K. Pharmaceutical quality assessment of different brands of moxifloxacin 400 mg tablets available in Pakistan. RADS J Pharm Pharm Sci. 2019;7(1):2-8.

Shailaja TS, Latha K. ALKabab AM, Yarragudi S, Uhumwangho MU. Formulation and evaluation of orodispersible tablets of metoprolol tartrate with natural and synthetic superdisintegrants. Int J Pharm Pharm Sci. 2012;4(3):148-54.

Mahatme A, Mahajan VR, Gudsoorkar VR. Formulation and evaluation of immediate-release tablet of amlodipine. Literati J Pharm Drug Deliv Technol. 2015;3:26-9.

Jassim Z, Hussein AA. Formulation and evaluation of clopidogrel tablet incorporating drug nanoparticles. Int J Pharm Pharm Sci. 2014;6(1):838-51.

Darwhekar N, Jain D, Chouhan J. Biopharmaceutical classification of candesartan and candesartan cilexetil. Asian J Pharm Life Sci. 2012;2:295-302.

The United States Pharmacopeia. USP30-NF25. Convention Inc Rockville MD General tests and assays CD; 2007.

Neamah AJ, Hasan A-GKM, Talib Khudhair AHK. Design and characterization of candesartan cilexetil oral nanoemulsion containing garlic oil. AL-Shaibani. Int J Appl Pharm. 2019;6:116-24.

Lalitha LJ, Chenthilnathan A, Vidyasagar V. Process validation of clopidogrel bisulphate 75-mg tablets. Pharm Lett. 2014;6(3):72-8.

Gupta MM, Patel V. Formulation and evaluation oral dispersible tablet of cinnarizine. J Drug Deliv Ther. 2013;3(2):12-7.

Satish NP, Satish KN. Design and optimization of fast dissolving tablets containing metoprolol by sublimation method. Int Res J Pharm. 2010;1(1):346-57.